pharma · Amyotrophic Lateral Sclerosis · Acute Myeloid Leukemia
AB Science
AB Science is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Amyotrophic Lateral Sclerosis, Acute Myeloid Leukemia, Mastocytosis, Mast cell activation syndrome, Multiple Scleros
PARIS, FR HQ
20 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- PARIS, FR
- Employees
- 20
- Programs
- 6
- Drugs
- 11
- Patents
- 25
AB19001
Phase 3 · small molecule · Amyotrophic Lateral Sclerosis
AB19001 for Amyotrophic Lateral Sclerosis is a Phase 3 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).
Internal code AB19001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AB Science
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Amyotrophic Lateral Sclerosis
- Status
- active
- Trials
- 1